Table 1.
Patient and clinical characteristics (n = 10)
| Characteristic | Number (%) of patients or Median (range) |
|---|---|
| Age (y) | 60 (38–71) |
| Sex | |
| Male | 6 (60%) |
| Female | 4 (40%) |
| Primary tumor | |
| Pancreas | 4 (40%) |
| Intestine | 2 (20%) |
| Lung | 2 (20%) |
| CUP | 2 20%) |
| Tumor grade | |
| G1 | 2 (20%) |
| G1/G2 (i.e., Ki-67 < 5%) | 2 (20%) |
| G2 | 6 (60%) |
| Ki-67 (%) | 5 (1–18) |
| Ongoing therapy at time of scan | |
| SSA only | 6 (60%) |
| SSA and everolimus | 2 (20%) |
| None | 2 (20%) |
| Interval [18F]AlF-OC and [68Ga]Ga-DOTATATE scan (days) | 9.5 (− 8 to + 35) |
| TNM stage | |
| T (0/1/2/3/4) | T (8/0/2/0) |
| N (0/1/2/3) | N (4/5/0/1) |
| M (0/M1a/M1b/M1c) | M (1/1/2/6) |